-
[1]
Yingying Hu
, Lin Lin
, Zhaopei Guo
, Jie Chen
, Atsushi Maruyama
, Huayu Tian
, Xuesi Chen
. In situ vaccination and gene-medeiated PD-L1 blockade for enhanced tumor immunotherapy. Chinese Chemical Letters,
2021, 32(5): 1770-1774.
doi: 10.1016/j.cclet.2020.12.055
-
[2]
Aiping Chen
, Yue Zhong
, Yunxiao Liu
, Zhancheng Xie
, Hanyu Wu
, Wei Shi
, Wenlong Huang
, Renxiang Tan
, Hai Qian
. Identification of highly efficacious PROTACs targeting BRD4 against acute myeloid leukemia: Design, synthesis, and biological evaluations. Chinese Chemical Letters,
2023, 34(6): 107923-1-107923-6.
doi: 10.1016/j.cclet.2022.107923
-
[3]
Yonghui Sun
, Xin Luo
, Zimo Yang
, Wenxing Lv
, Lixia Chen
, Hua Li
, Yu Rao
. Developing potent BTKC481S PROTACs for ibrutinib-resistant malignant lymphoma. Chinese Chemical Letters,
2023, 34(6): 107924-1-107924-6.
doi: 10.1016/j.cclet.2022.107924
-
[4]
Shen Lijun
, Zhou Tianjiao
, Fan Yatong
, Chang Xin
, Wang Yi
, Sun Jianguo
, Xing Lei
, Jiang Hulin
. Recent progress in tumor photodynamic immunotherapy. Chinese Chemical Letters,
2020, 31(7): 1709-1716.
doi: 10.1016/j.cclet.2020.02.007
-
[5]
Qi Luo
, Yunwei Zhang
, Zihua Wang
, Yining Sun
, Linqing Shi
, Yue Yu
, Jiyun Shi
, Zhiyuan Hu
, Fan Wang
. A novel peptide-based probe 99mTc-PEG6-RD-PDP2 for the molecular imaging of tumor PD-L2 expression. Chinese Chemical Letters,
2022, 33(7): 3497-3501.
doi: 10.1016/j.cclet.2022.02.068
-
[6]
Yuejia Song
, Yaqian Huang
, Fang Zhou
, Jinsong Ding
, Wenhu Zhou
. Macrophage-targeted nanomedicine for chronic diseases immunotherapy. Chinese Chemical Letters,
2022, 33(2): 597-612.
doi: 10.1016/j.cclet.2021.08.090
-
[7]
Hang Liu
, Zhaohua Miao
, Zhengbao Zha
. Cell membrane-coated nanoparticles for immunotherapy. Chinese Chemical Letters,
2022, 33(4): 1673-1680.
doi: 10.1016/j.cclet.2021.10.057
-
[8]
Zehua Hong
, Xin Zan
, Ting Yu
, Yuzhu Hu
, Hongfeng Gou
, Songping Zheng
, Xiang Gao
, Peizhi Zhou
. Local delivery of superagonist gene based on polymer nanoparticles for cancer immunotherapy. Chinese Chemical Letters,
2023, 34(3): 107603-1-107603-5.
doi: 10.1016/j.cclet.2022.06.026
-
[9]
Hanyong Wang
, Xinyu Yang
, Chunyan Hu
, Chenlu Huang
, Hai Wang
, Dunwan Zhu
, Linhua Zhang
. Programmed polymersomes with spatio-temporal delivery of antigen and dual-adjuvants for efficient dendritic cells-based cancer immunotherapy. Chinese Chemical Letters,
2022, 33(9): 4179-4184.
doi: 10.1016/j.cclet.2022.02.022
-
[10]
Xiang Sun
, Yanmin Wang
, Tao Du
, Qiang Zhang
, Shuo Li
, Qinda Chen
, Miao Wang
, Xiumin Wang
, Lei Ren
, Xueqin Zhao
. Indocyanine green-/TLR7 agonist-constructed thermosensitive liposome for low-temperature PTT induced synergistic immunotherapy of colorectal cancer. Chinese Chemical Letters,
2023, 34(5): 108201-1-108201-6.
doi: 10.1016/j.cclet.2023.108201
-
[11]
Chunlan Pu
, Shirui Wang
, Lei Liu
, Zhonghui Feng
, Hongjia Zhang
, Qianyuan Gong
, Yueshan Sun
, Yuanbiao Guo
, Rui Li
. Current strategies for improving limitations of proteolysis targeting chimeras. Chinese Chemical Letters,
2023, 34(6): 107927-1-107927-13.
doi: 10.1016/j.cclet.2022.107927
-
[12]
Chunying Li
, Yifan Zhang
, Yilin Wan
, Jingle Wang
, Jing Lin
, Zhiming Li
, Peng Huang
. STING-activating drug delivery systems: Design strategies and biomedical applications. Chinese Chemical Letters,
2021, 32(5): 1615-1625.
doi: 10.1016/j.cclet.2021.01.001
-
[13]
Ruixuan Chen
, Ping Ouyang
, Licong Su
, Xi Xu
, Penghu Lian
, Yanqin Li
, Qi Gao
, Yifan Zhang
, Sheng Nie
, Fan Luo
, Ruqi Xu
, Xiaodong Zhang
, Xiaoxi Li
, Yue Cao
, Peiyan Gao
, Juanjuan Kang
, Jun Wu
, Lu Li
. Nanoparticles targeting at methylases with high correlation to N6-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma. Chinese Chemical Letters,
2022, 33(10): 4610-4616.
doi: 10.1016/j.cclet.2022.03.074
-
[14]
Tianqi Wang
, Yanan Fu
, Shengjie Sun
, Chenyi Huang
, Yunfei Yi
, Junqing Wang
, Yang Deng
, Meiying Wu
. Exosome-based drug delivery systems in cancer therapy. Chinese Chemical Letters,
2023, 34(2): 107508-1-107508-8.
doi: 10.1016/j.cclet.2022.05.022
-
[15]
Yanan Li
, Jing Cui
, Chenlong Li
, Caiting Deng
, Guowei Deng
, Hui Zhang
, Feifei An
. Biomaterial-assisted photoimmunotherapy for synergistic suppression of cancer progression. Chinese Chemical Letters,
2023, 34(9): 108180-1-108180-9.
doi: 10.1016/j.cclet.2023.108180
-
[16]
Xiaojun Yu
, Haitao Ma
, Guiying Xu
, Zhuang Liu
. Radiotherapy assisted with biomaterials to trigger antitumor immunity. Chinese Chemical Letters,
2022, 33(9): 4169-4174.
doi: 10.1016/j.cclet.2022.02.049
-
[17]
Jing Gao
, Hanwu Zhang
, Fengqi Zhou
, Bo Hou
, Meiwan Chen
, Zhigang Xie
, Haijun Yu
. Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition. Chinese Chemical Letters,
2021, 32(6): 1929-1936.
doi: 10.1016/j.cclet.2020.12.009
-
[18]
Lin Zhai
, Yujie Shi
, Yi Yan
, An Lu
, Xiaoyu Liu
, Lei Lei
, Yi Sun
, Linxia Jiang
, Xiangyu Wang
, Honggang Qian
, Jiancheng Wang
. Local sustained release of PD-1 monoclonal antibody and lenvatinib by thermo-sensitive hydrogel for improving tumor immunotherapy. Chinese Chemical Letters,
2023, 34(8): 108104-1-108104-7.
doi: 10.1016/j.cclet.2022.108104
-
[19]
Han Lin
, Haofei Hong
, Lipeng Feng
, Jie Shi
, Zhifang Zhou
, Zhimeng Wu
. Synthesis of DNP-modified GM3-based anticancer vaccine and evaluation of its immunological activities for cancer immunotherapy. Chinese Chemical Letters,
2021, 32(12): 4041-4044.
doi: 10.1016/j.cclet.2021.04.034
-
[20]
Qiang Zeng
, Zhigang Liu
, Ting Niu
, Chuan He
, Ying Qu
, Zhiyong Qian
. Application of nanotechnology in CAR-T-cell immunotherapy. Chinese Chemical Letters,
2023, 34(3): 107747-1-107747-17.
doi: 10.1016/j.cclet.2022.107747